November 20, 2023, Dexcom Inc (NASDAQ: DXCM) trading session started at the price of $104.39, that was 3.80% jump from the session before. During the day, the shares moved up to $109.20 and dropped to $104.06 before settling in for the closing price of $104.97. A 52-week range for DXCM has been $74.75 – $139.55.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 32.62%. When this article was written, the company’s average yearly earnings per share was at 63.49%. With a float of $380.80 million, this company’s outstanding shares have now reached $386.30 million.
Considering the fact that the conglomerate employs 7600 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is +64.46, operating margin of +13.44, and the pretax margin is +13.43.
Dexcom Inc (DXCM) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dexcom Inc stocks. The insider ownership of Dexcom Inc is 1.44%, while institutional ownership is 97.21%. The most recent insider transaction that took place on Nov 15, was worth 101,256. In this transaction Director of this company sold 1,000 shares at a rate of $101.26, taking the stock ownership to the 59,700 shares. Before that another transaction happened on Nov 08, when Company’s EVP Operations sold 2,019 for $95.22, making the entire transaction worth $192,249. This insider now owns 64,250 shares in total.
Dexcom Inc (DXCM) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted $0.5 earnings per share (EPS) during the time that was better than consensus figure (set at $0.34) by $0.16. This company achieved a net margin of +11.73 while generating a return on equity of 15.57. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.49% per share during the next fiscal year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
You can see what Dexcom Inc (DXCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.37. Likewise, its price to free cash flow for the trailing twelve months is 84.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.90, a number that is poised to hit 0.42 in the next quarter and is forecasted to reach 1.70 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Compared to the last year’s volume of 3.38 million, its volume of 5.0 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 94.66%. Additionally, its Average True Range was 4.31.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 52.79%, which indicates a significant decrease from 98.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.61% in the past 14 days, which was lower than the 47.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $91.06, while its 200-day Moving Average is $111.38. Nevertheless, the first resistance level for the watch stands at $110.75 in the near term. At $112.55, the stock is likely to face the second major resistance level. The third major resistance level sits at $115.89. If the price goes on to break the first support level at $105.61, it is likely to go to the next support level at $102.27. Now, if the price goes above the second support level, the third support stands at $100.47.
Dexcom Inc (NASDAQ: DXCM) Key Stats
There are 386,374K outstanding shares of the company, which has a market capitalization of 42.10 billion. As of now, sales total 2,910 M while income totals 341,200 K. Its latest quarter income was 975,000 K while its last quarter net income were 120,700 K.